ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is NovaBay Pharmaceuticals, Inc. ?
Unrated Stock - No Analysis Available
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-21.92%
EBIT Growth (5y)
-0.44%
EBIT to Interest (avg)
-6.70
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.32
Sales to Capital Employed (avg)
4.79
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.13%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
23.18
EV to EBIT
-5.13
EV to EBITDA
-5.29
EV to Capital Employed
-36.14
EV to Sales
12.77
PEG Ratio
NA
Dividend Yield
76.16%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-449.39%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bearish
Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
NET SALES(9M)
At USD 0.52 MM has Grown at inf%
RAW MATERIAL COST(Y)
Fallen by -806% (YoY
OPERATING PROFIT(Q)
Highest at USD -1.14 MM
PRE-TAX PROFIT(Q)
Highest at USD -1.25 MM
NET PROFIT(Q)
Highest at USD -1.25 MM
EPS(Q)
Highest at USD -0.22
-5What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -7.01 MM
ROCE(HY)
Lowest at -587.58%
Here's what is working for NovaBay Pharmaceuticals, Inc.
Net Sales
At USD 0.52 MM has Grown at inf%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Operating Profit
Highest at USD -1.14 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD -1.25 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -1.25 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.22
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -806% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for NovaBay Pharmaceuticals, Inc.
Operating Cash Flow
Lowest at USD -7.01 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
